Bumper Offer - Urjas oil Just @ Rs. 1
Minoz 50 Tablet is a prescription drug, available for use as Tablet. Primarily, it is used for the treatment of Bacterial Infections. Secondary and off-label uses of Minoz 50 Tablet have also been mentioned below.
The correct dosage of Minoz 50 Tablet depends on the patient's age, gender, and medical history. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
Some other side effects of Minoz 50 Tablet have been listed ahead. These side effects of Minoz 50 Tablet are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Minoz 50 Tablet is Severe for pregnant women and Severe for women who are breastfeeding. It is important to know if Minoz 50 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Minoz 50 Tablet related warnings section.
Other conditions have been mentioned below in the Minoz 50 Tablet contraindications section.
Drug interactions for Minoz 50 Tablet have been reported in the medical literature. See below for a complete list.
In addition to these precautions, you may also note that Minoz 50 Tablet is not safe while driving, and is is not addictive in nature.
Minoz 50 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Minoz 50 Tablet is used -
Moderate
Mild
Is the use of Minoz 50 Tablet safe for pregnant women?
Minoz has many dangerous side effects in pregnant women. If you are pregnant, do not consume Minoz without medical advice.
Is the use of Minoz 50 Tablet safe during breastfeeding?
Minoz should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Minoz 50 Tablet on the Kidneys?
Kidney can be affected by Minoz. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Minoz 50 Tablet on the Liver?
Very few cases of side effects of Minoz on the liver have been reported.
What is the effect of Minoz 50 Tablet on the Heart?
Minoz is not harmful for the heart.
Minoz 50 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Minoz 50 Tablet unless your doctor advises you to do so -
Is this Minoz 50 Tablet habit forming or addictive?
Minoz 50 Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Minoz 50 Tablet. So it is best to avoid driving.
Is it safe?
Yes, Minoz 50 Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Minoz 50 Tablet for mental disorders.
Interaction between Food and Minoz 50 Tablet
Taking Minoz 50 Tablet with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Minoz 50 Tablet
Due to lack of research, there is no information about the side effects of taking Minoz 50 Tablet with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Minocin® (minocycline hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 782-783
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1191-1195
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Minocin® (minocycline hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 782-783
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1191-1195
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Minocin® (minocycline hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 782-783
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1191-1195
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Minocin® (minocycline hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 782-783
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1191-1195
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Minocin® (minocycline hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 782-783
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1191-1195
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Minocin® (minocycline hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 782-783
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1191-1195
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Minocin® (minocycline hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 782-783
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1191-1195
